Finance

Lists
Why is 019175 down 2,32%?
Dive Deeper
019175:KRX
Shinpoong Pharmaceutical Co Ltd Preference Shares
13 900,00 KRW
-2,32%
(-330,00) 1D
15-окт., 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 019175...
Open
14 110 KRW
High
14 440 KRW
Low
13 020 KRW
Mkt. cap
509,37 млд
Avg. vol.
6,72 миң
Volume
6,32 миң
52-wk high
28 500 KRW
52-wk low
7 570 KRW
EPS
-20 KRW
Shares outstanding
1,99 млн
No. of employees
656
Open
14 110 KRW
High
14 440 KRW
Low
13 020 KRW
Mkt. cap
509,37 млд
Avg. vol.
6,72 миң
Volume
6,32 миң
52-wk high
28 500 KRW
52-wk low
7 570 KRW
EPS
-20 KRW
Shares outstanding
1,99 млн
No. of employees
656
News stories
From web sources and news partners
About Shinpoong Pharmaceutical Co Ltd Preference Shares
CEOYoo Je-man
Employees656
Founded1962
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
62,61 млд
58,04 млд
54,53 млд
63,89 млд
Cost of goods sold
33,91 млд
33,04 млд
33,12 млд
36,90 млд
Cost of revenue
33,91 млд
33,04 млд
33,12 млд
36,90 млд
Research and development expenses
2,39 млд
1,77 млд
4,19 млд
2,89 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,41 млд
19,16 млд
18,01 млд
30,48 млд
Operating expense
21,48 млд
21,14 млд
21,77 млд
35,02 млд
Total operating expenses
55,39 млд
54,17 млд
54,89 млд
71,92 млд
Operating income
7,22 млд
3,87 млд
-363,22 млн
-8,03 млд
Other non operating income
37,58 млн
56,74 млн
-42,52 млн
32,83 млн
EBT including unusual items
7,26 млд
302,61 млн
439,87 млн
-8,00 млд
EBT excluding unusual items
7,26 млд
3,25 млд
423,63 млн
-8,01 млд
Income tax expense
847,52 млн
-147,88 млн
70,67 млн
-18,14 млн
Effective tax rate
11,67%
-48,87%
16,07%
0,23%
Other operating expenses
43,68 млн
-434,64 млн
105,86 млн
379,89 млн
Net income
6,38 млд
461,37 млн
358,51 млн
-8,01 млд
Net profit margin
10,19%
0,79%
0,66%
-12,54%
Earnings per share
-
-
-
-
Interest and investment income
208,75 млн
200,34 млн
246,20 млн
432,18 млн
Interest expense
-642,57 млн
-671,63 млн
-862,72 млн
-856,95 млн
Net interest expenses
-433,82 млн
-471,28 млн
-616,52 млн
-424,77 млн
Depreciation and amortization charges
528,97 млн
372,83 млн
362,48 млн
332,80 млн
EBITDA
10,17 млд
6,67 млд
2,42 млд
-5,26 млд
Gain or loss from assets sale
-19,00 миң
-1,82 млн
-12,35 млн
-6,89 млн
AI content may include mistakes. Learn more
Google колдонмолору